9to5Mac

New Apple Vision Pro study reveals promising performance in radiology

A new study published this week by researchers at the University of California, San Diego highlights how Apple Vision Pro can be used in healthcare settings. In particular, this study sought to ...
Seeking Alpha

Neurocrine Biosciences Presents Patient-Reported Outcomes from KINECT-PRO™ Study Demonstrating INGREZZA® (valbenazine) Capsules Improved Functionality and Quality of Life in ...

SAN DIEGO, June 2, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) today announced new data from the Phase 4 KINECT-PRO TM open-label study demonstrating robust and sustained ...
Seeking Alpha

Neurocrine Biosciences Reports Patient-Reported Outcome Data from KINECT-PRO™ Study for INGREZZA® (valbenazine) Capsules in Tardive Dyskinesia: Significant and Clinically ...

SAN DIEGO, Feb. 27, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) today announced top-line data from a Phase 4 study, KINECT-PRO™, demonstrating clinically meaningful and ...
Yahoo Finance

Sharp HealthCare Launches New Apple Vision Pro Study in Eye Microsurgery

SAN DIEGO, April 15, 2026 /PRNewswire/ -- Sharp HealthCare, through its Spatial Computing Center of Excellence, has launched an Institutional Review Board (IRB) approved clinical study evaluating the ...